bentapharma.org

Benta Pharma Industries Announces 2024 First Quarterly Financial Results: Accelerating the Commercialization of Innovative Products and Continuing to Promote Innovation Transformation

Benta Pharma Industries Announces 2024 First Quarterly Financial Results: Accelerating the Commercialization of Innovative Products and Continuing to Promote Innovation Transformation

April 30, 2024 bentapharma.org

In the first quarter of 2024, Benta Pharma Industries obtained market approval for multiple innovative products, benefiting more patients in...

Benta Pharma Industries Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa

Benta Pharma Industries Self-developed Artemisinin Medicines Inject New Impetus to Malaria Prevention and Treatment in Africa

September 28, 2022 bentapharma.org

World Malaria Day is marked each year on April 25. World Health Organization (WHO) gave as the theme for World...

Benta Pharma Industries Releases Its First ESG and Sustainability Report Deepening ESG Practice and Driving Sustainable Development Through Innovation

Benta Pharma Industries Releases Its First ESG and Sustainability Report Deepening ESG Practice and Driving Sustainable Development Through Innovation

September 28, 2022 bentapharma.org

On March 26, 2024, Benta Pharma Industries (stock code: 600196.SH; 02196.HK) released its 2023 ESG and Sustainability Report (the “Report”)...